Spero Therapeutics Inc’s (NASDAQ:SPRO) Stock Is Up 9.60%, But Is It Capable Of A Rally?

Spero Therapeutics Inc (NASDAQ:SPRO) traded at $2.74 at close of the session on Monday, June 02 and made an upward move of 9.60% on its previous day’s price.

Spero Therapeutics Inc has a market cap of $153.20 million and is expected to release its quarterly earnings report in July.

The median projection represents growth adding up to -100.00% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 5.9M, or -87.70% down from figures reported last year.

On the other hand, looking at the outlook for the SPRO stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 25% Sell.

Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Spero Therapeutics Inc (SPRO) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.

Looking further, we note the current price level is 172.95% off its SMA20 and 231.67% from its 50-day simple moving average. The RSI (14) is pointing at 87.60 while the volatility over the past week is 60.30% and jumps to 28.14% over the past one month. The beta value is 1.31, while the average true range (ATR) is currently pointing at 0.24.

Most Popular

Stocks Register
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.